Drug Shows Promise in Preventing Multiple Sclerosis Relapses
A new injectable drug called ofatumumab helped reduce multiple sclerosis relapses in a phase III clinical trial. The drug is
Read more
A new injectable drug called ofatumumab helped reduce multiple sclerosis relapses in a phase III clinical trial. The drug is
Read moreDelaying vaccination increases the risk of getting one of the diseases. The annual update to childhood and adolescent vaccine schedules
Read more